http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090130427-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8726f713a6d86892687edccfa03d886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
filingDate 2008-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_237cee4ca56951f442b2d245c09d7631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfdf20bf3037e4ad2b07c8c67153268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33241c42a435045bb23cdcdc9df5399f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45d29850fe23082ff7d1b5fb46c4fa99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b9d16b56ed909736704d9411e19238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429c8cac6857d98e749345724e9bbf7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3667e33d46d4c9cf3adb7486bb7fc9be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc7dae6491abcb54fbcd499381ef6c8
publicationDate 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090130427-A
titleOfInvention Compounds and Compositions as C-VIT and PDWF Kinase Inhibitors
abstract The present invention is directed to treating a new class of compounds, pharmaceutical compositions comprising said compounds, diseases or disorders associated with abnormal or deregulated kinase activity, in particular diseases or disorders involving abnormal activation of c-kit, PDGFRα and PDGFRβ kinases. A method of using said compound for prophylaxis.
priorityDate 2007-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465349299
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID464987544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421579847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465166800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421217316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163568459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25114637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163442442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163696030

Total number of triples: 73.